Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune pancreatitis].

Philippe Lévy1, Pascal Hammel, Philippe Ruszniewski

  • 1Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, Clichy, France. philippe.levy@bjn.aphp.fr

Presse Medicale (Paris, France : 1983)
|May 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study.

medRxiv : the preprint server for health sciences·2026
Same author

Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.

Annals of surgical oncology·2026
Same author

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

The New England journal of medicine·2026
Same author

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Lancet (London, England)·2026
Same author

Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

JCO clinical cancer informatics·2026
Same author

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.

JCO global oncology·2026
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Chronic autoimmune pancreatitis (CAP) presents distinct symptoms and imaging findings, differing from other chronic pancreatitis types. Early consideration of CAP is crucial for accurate diagnosis and appropriate treatment, especially in cases of pancreatic tumors.

Area of Science:

  • Gastroenterology
  • Immunology
  • Oncology

Background:

  • Chronic autoimmune pancreatitis (CAP) is a distinct entity from other chronic pancreatitis forms.
  • CAP can manifest with acute or chronic pancreatitis signs, potentially causing cholestatic jaundice.
  • Imaging may reveal diffuse (duct-destructive) or pseudotumoral lesions, possibly representing different clinical subtypes.

Purpose of the Study:

  • To differentiate chronic autoimmune pancreatitis from other pancreatic conditions.
  • To highlight the association of CAP with other autoimmune and intestinal inflammatory diseases.
  • To emphasize the importance of considering CAP in pancreatic tumor diagnostics.

Main Methods:

  • Clinical evaluation of pancreatitis symptoms and patient history.

Related Experiment Videos

  • Radiological imaging interpretation (e.g., CT, MRI) for lesion characterization.
  • Review of associations with other autoimmune diseases and inflammatory bowel diseases.

    • Main Results:

    • CAP presents unique clinical and imaging features.
    • Associations exist between CAP and autoimmune disorders (e.g., bile duct disease) and inflammatory bowel diseases (Crohn's, ulcerative colitis).
    • CAP should be suspected in pancreatic tumors lacking definitive features of adenocarcinoma.

    Conclusions:

    • Chronic autoimmune pancreatitis requires routine consideration in specific clinical scenarios.
    • Distinguishing CAP from pancreatic adenocarcinoma is critical for treatment decisions, as therapies differ significantly.
    • Further research is needed to clarify the diagnostic role of serologic markers and autoantibodies in CAP.